Mackenzie Financial Corp Makes New Investment in Enfusion, Inc. (NYSE:ENFN)

Mackenzie Financial Corp purchased a new stake in shares of Enfusion, Inc. (NYSE:ENFNFree Report) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 22,517 shares of the company’s stock, valued at approximately $192,000.

Other institutional investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC purchased a new stake in Enfusion in the first quarter valued at approximately $44,000. RiverPark Advisors LLC purchased a new stake in shares of Enfusion during the 2nd quarter valued at $68,000. Arizona State Retirement System bought a new stake in shares of Enfusion during the 2nd quarter worth $86,000. Price T Rowe Associates Inc. MD purchased a new position in Enfusion in the first quarter worth $102,000. Finally, Quadrature Capital Ltd bought a new position in Enfusion in the first quarter valued at $109,000. Institutional investors own 81.05% of the company’s stock.

Enfusion Trading Down 0.6 %

Shares of NYSE ENFN opened at $8.95 on Tuesday. The stock’s 50-day moving average is $8.52 and its 200 day moving average is $8.89. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of 298.17, a P/E/G ratio of 2.63 and a beta of 0.92. Enfusion, Inc. has a 1-year low of $7.52 and a 1-year high of $10.45.

Enfusion (NYSE:ENFNGet Free Report) last released its earnings results on Tuesday, August 6th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The company had revenue of $49.46 million during the quarter, compared to the consensus estimate of $50.27 million. Enfusion had a net margin of 1.98% and a return on equity of 6.17%. On average, analysts forecast that Enfusion, Inc. will post 0.07 EPS for the current fiscal year.

Enfusion Profile

(Free Report)

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.

Further Reading

Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFNFree Report).

Institutional Ownership by Quarter for Enfusion (NYSE:ENFN)

Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.